Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.1264
+0.0082
+(6.94%)
At close: April 4 at 4:56:28 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | 1 |
Avg. Estimate | -- | -- | -- | 22.3M |
Low Estimate | -- | -- | -- | 22.3M |
High Estimate | -- | -- | -- | 22.3M |
Year Ago Sales | -- | -- | 11.64M | -- |
Sales Growth (year/est) | -- | -- | -100.00% | 0.00% |
EPS Trend
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
LPGO.ST | -- | -- | -- | -- |
S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Related Tickers
CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
LIDDS.ST LIDDS AB (publ)
0.0600
+55.44%
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%
2CUREX.ST 2cureX AB (publ)
0.3500
-6.17%
FLUI.ST Fluicell AB (publ)
11.66
-14.89%
STABL.ST Stayble Therapeutics AB (publ)
0.4480
-10.40%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
IMMU.ST Mendus AB (publ)
5.70
+2.46%
CANTA.ST Cantargia AB (publ)
1.2950
-2.04%
ALZCUR.ST AlzeCure Pharma AB (publ)
2.6100
+9.66%